CD47 predominates over CD24 as a macrophage immune checkpoint in cancer.
Juliet Allen, Anna Meglan, Kyle Vaccaro…·Kipp Weiskopf
This study identifies CD47 as a more effective macrophage immune checkpoint than CD24 in cancer and develops bispecific antibodies to enhance macrophage-mediated tumor killing.